133 related articles for article (PubMed ID: 25190084)
21. New Perspectives in Glioblastoma: Nanoparticles-based Approaches.
Luciano R; Battafarano G; Saracino R; Rossi M; Perrotta A; Manco M; Muraca M; Del Fattore A
Curr Cancer Drug Targets; 2017; 17(3):203-220. PubMed ID: 27528362
[TBL] [Abstract][Full Text] [Related]
22. [New therapeutic options in therapy of glioblastoma multiforme].
Lakomý R; Burkon P; Burkonová D; Jancálek R
Klin Onkol; 2010; 23(6):381-7. PubMed ID: 21351415
[TBL] [Abstract][Full Text] [Related]
23. Glioblastoma multiforme--new approaches to therapy.
Baehring JM
Cancer J; 2012; 18(1):11. PubMed ID: 22290251
[No Abstract] [Full Text] [Related]
24. Non-antisense oligonucleotide approaches for experimental treatment of glioblastoma.
Neckers LM; Kanekal M; Connell Y
Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):177-9. PubMed ID: 9593060
[No Abstract] [Full Text] [Related]
25. The cost and value of glioblastoma therapy.
Cagney DN; Alexander BM
Expert Rev Anticancer Ther; 2017 Aug; 17(8):657-659. PubMed ID: 28689438
[No Abstract] [Full Text] [Related]
26. Glioblastoma treatment.
Slatkin DN
Science; 1994 Sep; 265(5179):1644. PubMed ID: 7993457
[No Abstract] [Full Text] [Related]
27. [Gene therapy of glioblastoma].
Astrup J
Ugeskr Laeger; 2001 Apr; 163(15):2147. PubMed ID: 11332215
[No Abstract] [Full Text] [Related]
28. Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma?
Weller M; Wick W
Neuro Oncol; 2011 Apr; 13(4):365-6. PubMed ID: 21430110
[No Abstract] [Full Text] [Related]
29. Glioblastoma Therapy in the Age of Molecular Medicine.
Geraldo LHM; Garcia C; da Fonseca ACC; Dubois LGF; de Sampaio E Spohr TCL; Matias D; de Camargo Magalhães ES; do Amaral RF; da Rosa BG; Grimaldi I; Leser FS; Janeiro JM; Macharia L; Wanjiru C; Pereira CM; Moura-Neto V; Freitas C; Lima FRS
Trends Cancer; 2019 Jan; 5(1):46-65. PubMed ID: 30616755
[TBL] [Abstract][Full Text] [Related]
30. Management of glioblastoma multiforme by irradiation and chemotherapy.
Shehata WM; Meyer RL; Jazy FK; Tew JM; Hall JM; Ignatius J; Reed RL; Liwnicz BH
IMJ Ill Med J; 1983 Jan; 163(1):30-4. PubMed ID: 6131056
[No Abstract] [Full Text] [Related]
31. [Letter: Therapy of brain neoplasms].
Hansen HH; Dombernowsky P
Ugeskr Laeger; 1974 Mar; 136(12):653-4. PubMed ID: 4362659
[No Abstract] [Full Text] [Related]
32. Glioblastoma multiforme: introduction.
Markert J
Cancer J; 2003; 9(2):71. PubMed ID: 12784871
[No Abstract] [Full Text] [Related]
33. Glioblastoma in elderly patients.
Coulter IC; Varma A; Kane PJ; Mukerji N
J Neurosurg; 2014 May; 120(5):1246-7. PubMed ID: 24579663
[No Abstract] [Full Text] [Related]
34. Editorial: glioblastoma in the elderly.
Heros DO; Heros RC
J Neurosurg; 2013 Apr; 118(4):783-5; discussion 784-5. PubMed ID: 23176332
[No Abstract] [Full Text] [Related]
35. What next for newly diagnosed glioblastoma?
Domingo-Musibay E; Galanis E
Future Oncol; 2015; 11(24):3273-83. PubMed ID: 26558493
[TBL] [Abstract][Full Text] [Related]
36. Gene therapeutics: the future of brain tumor therapy?
Cutter JL; Kurozumi K; Chiocca EA; Kaur B
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1053-64. PubMed ID: 16831077
[TBL] [Abstract][Full Text] [Related]
37. First-in-class antimitotic device approved for glioblastoma.
Oncology (Williston Park); 2011 May; 25(6):546. PubMed ID: 21717911
[No Abstract] [Full Text] [Related]
38. The innovative therapies that could break the brain-cancer stalemate.
Willyard C
Nature; 2018 Sep; 561(7724):S59-S61. PubMed ID: 30258164
[No Abstract] [Full Text] [Related]
39. Recent updates in the treatment of glioblastoma: introduction.
Mehta M; Brem S
Semin Oncol; 2014 Oct; 41 Suppl 6():S1-3. PubMed ID: 25213868
[No Abstract] [Full Text] [Related]
40. 3D-Bioprinted Mini-Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics.
Heinrich MA; Bansal R; Lammers T; Zhang YS; Michel Schiffelers R; Prakash J
Adv Mater; 2019 Apr; 31(14):e1806590. PubMed ID: 30702785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
